Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.
Publication
, Journal Article
Povsic, TJ
Published in: Circ Res
February 16, 2018
Duke Scholars
Published In
Circ Res
DOI
EISSN
1524-4571
Publication Date
February 16, 2018
Volume
122
Issue
4
Start / End Page
552 / 554
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Regenerative Medicine
- Humans
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Povsic, T. J. (2018). Approaching Regulatory Approval of Cardiovascular Regenerative Therapy. Circ Res, 122(4), 552–554. https://doi.org/10.1161/CIRCRESAHA.117.312520
Povsic, Thomas J. “Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.” Circ Res 122, no. 4 (February 16, 2018): 552–54. https://doi.org/10.1161/CIRCRESAHA.117.312520.
Povsic TJ. Approaching Regulatory Approval of Cardiovascular Regenerative Therapy. Circ Res. 2018 Feb 16;122(4):552–4.
Povsic, Thomas J. “Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.” Circ Res, vol. 122, no. 4, Feb. 2018, pp. 552–54. Pubmed, doi:10.1161/CIRCRESAHA.117.312520.
Povsic TJ. Approaching Regulatory Approval of Cardiovascular Regenerative Therapy. Circ Res. 2018 Feb 16;122(4):552–554.
Published In
Circ Res
DOI
EISSN
1524-4571
Publication Date
February 16, 2018
Volume
122
Issue
4
Start / End Page
552 / 554
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Regenerative Medicine
- Humans
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences